Annual Accounts Receivable
N/A
December 31, 2023
Summary
- ATAI annual accounts receivable is not available.
Performance
ATAI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- ATAI quarterly accounts receivable is not available.
Performance
ATAI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ATAI Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ATAI Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Atai Life Sciences NV Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $46.60 K(-23.1%) |
| Jun 2022 | - | $60.60 K(+9.4%) |
| Mar 2022 | - | $55.40 K(-62.4%) |
| Dec 2021 | $147.20 K(-57.2%) | $147.20 K(+90.4%) |
| Sep 2021 | - | $77.30 K(-29.7%) |
| Jun 2021 | - | $110.00 K(+1.8%) |
| Mar 2021 | - | $108.10 K(-68.5%) |
| Dec 2020 | $343.70 K(+1019.5%) | $343.70 K(+211.9%) |
| Sep 2020 | - | $110.20 K(-2.8%) |
| Jun 2020 | - | $113.40 K(+69.5%) |
| Mar 2020 | - | $66.90 K(+117.9%) |
| Dec 2019 | $30.70 K(-52.0%) | - |
| Dec 2019 | - | $30.70 K(-75.1%) |
| Sep 2019 | - | $123.40 K(-13.1%) |
| Jun 2019 | - | $142.00 K(-25.4%) |
| Mar 2019 | - | $190.30 K(+197.8%) |
| Dec 2018 | $63.90 K(+688.9%) | $63.90 K(+6.5%) |
| Sep 2018 | - | $60.00 K(+2900.0%) |
| Jun 2018 | - | $2000.00(-63.6%) |
| Mar 2018 | - | $5500.00(-99.9%) |
| Dec 2017 | $8100.00(-99.9%) | - |
| Sep 2017 | - | $9.29 M(-29.7%) |
| Jun 2017 | - | $13.21 M(+62.1%) |
| Mar 2017 | $8.15 M(+4.3%) | $8.15 M(-19.8%) |
| Dec 2016 | - | $10.16 M(-26.3%) |
| Sep 2016 | - | $13.78 M(+18.9%) |
| Jun 2016 | - | $11.59 M(+48.2%) |
| Mar 2016 | $7.82 M(+0.8%) | $7.82 M(-27.6%) |
| Dec 2015 | - | $10.80 M(-8.8%) |
| Sep 2015 | - | $11.84 M(+12.7%) |
| Jun 2015 | - | $10.51 M(+35.5%) |
| Mar 2015 | $7.76 M | $7.76 M(+8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | - | $7.17 M(-60.1%) |
| Sep 2014 | - | $17.97 M(+123.8%) |
| Jun 2014 | - | $8.03 M(-27.1%) |
| Mar 2014 | $11.02 M(+33.9%) | $11.02 M(+21.5%) |
| Dec 2013 | - | $9.06 M(-1.5%) |
| Sep 2013 | - | $9.21 M(-44.7%) |
| Jun 2013 | - | $16.66 M(+102.5%) |
| Mar 2013 | $8.22 M(-36.5%) | $8.22 M(-25.8%) |
| Dec 2012 | - | $11.09 M(+6.2%) |
| Sep 2012 | - | $10.44 M(-4.5%) |
| Jun 2012 | - | $10.93 M(-15.7%) |
| Mar 2012 | $12.96 M(+80.9%) | $12.96 M(-13.0%) |
| Dec 2011 | - | $14.90 M(+14.3%) |
| Sep 2011 | - | $13.03 M(+71.0%) |
| Jun 2011 | - | $7.62 M(+6.4%) |
| Mar 2011 | $7.16 M(-40.9%) | $7.16 M(-45.2%) |
| Jun 2010 | - | $13.08 M(+7.9%) |
| Mar 2010 | $12.13 M(+16.5%) | $12.13 M(+35.3%) |
| Dec 2009 | - | $8.96 M(-30.1%) |
| Sep 2009 | - | $12.82 M(+10.8%) |
| Jun 2009 | - | $11.57 M(+11.1%) |
| Mar 2009 | $10.41 M(+14.8%) | $10.41 M(-0.4%) |
| Dec 2008 | - | $10.46 M(-9.9%) |
| Sep 2008 | - | $11.61 M(+23.2%) |
| Jun 2008 | - | $9.42 M(+3.9%) |
| Mar 2008 | $9.07 M(+312.5%) | $9.07 M(-1.6%) |
| Dec 2007 | - | $9.21 M(+133.1%) |
| Sep 2007 | - | $3.95 M(+79.7%) |
| Mar 2007 | $2.20 M(+35.6%) | $2.20 M |
| Mar 2006 | $1.62 M(+22.2%) | - |
| Mar 2004 | $1.33 M(+113.5%) | - |
| Dec 2003 | $621.30 K | - |
FAQ
- What is the all time high annual accounts receivable for Atai Life Sciences NV?
- What is the all time high quarterly accounts receivable for Atai Life Sciences NV?
What is the all time high annual accounts receivable for Atai Life Sciences NV?
Atai Life Sciences NV all-time high annual accounts receivable is $12.96 M
What is the all time high quarterly accounts receivable for Atai Life Sciences NV?
Atai Life Sciences NV all-time high quarterly accounts receivable is $17.97 M